Stem cell jab aims to ease knee arthritis without surgery
Disease control
Not yet recruiting
This study tests whether a single injection of stem cells (MAG200) can reduce pain and improve daily function in people with knee osteoarthritis. About 573 adults aged 35–75 with moderate knee arthritis will receive either a low dose, high dose, or placebo shot. The goal is to se…
Phase: PHASE3 • Sponsor: Magellan Stem Cells • Aim: Disease control
Last updated Apr 26, 2026 20:02 UTC